Cameco Corporation $CCJ Shares Sold by Galilei Investment Office LLP

Galilei Investment Office LLP decreased its position in Cameco Corporation (NYSE:CCJ) (TSE:CCO) by 30.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,075 shares of the basic materials company’s stock after selling 470 shares during the quarter. Cameco accounts for about 0.0% of Galilei Investment Office LLP’s holdings, making the stock its 27th biggest holding. Galilei Investment Office LLP’s holdings in Cameco were worth $80,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the company. Envestnet Portfolio Solutions Inc. acquired a new stake in Cameco in the second quarter valued at approximately $202,000. Concord Wealth Partners acquired a new stake in Cameco in the second quarter valued at approximately $103,000. Sequoia Financial Advisors LLC raised its holdings in Cameco by 5.0% in the second quarter. Sequoia Financial Advisors LLC now owns 87,099 shares of the basic materials company’s stock valued at $6,465,000 after acquiring an additional 4,160 shares in the last quarter. Total Clarity Wealth Management Inc. acquired a new stake in Cameco in the second quarter valued at approximately $281,000. Finally, Yousif Capital Management LLC raised its holdings in Cameco by 6.5% in the second quarter. Yousif Capital Management LLC now owns 6,965 shares of the basic materials company’s stock valued at $517,000 after acquiring an additional 425 shares in the last quarter. Institutional investors and hedge funds own 70.21% of the company’s stock.

Cameco Stock Performance

NYSE:CCJ opened at $92.09 on Tuesday. The firm’s fifty day moving average price is $80.01 and its 200 day moving average price is $66.32. Cameco Corporation has a 1-year low of $35.00 and a 1-year high of $94.36. The company has a debt-to-equity ratio of 0.15, a current ratio of 2.96 and a quick ratio of 2.00. The firm has a market cap of $40.09 billion, a price-to-earnings ratio of 105.85 and a beta of 0.99.

Cameco (NYSE:CCJ) (TSE:CCO) last posted its quarterly earnings data on Thursday, July 31st. The basic materials company reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.29 by $0.22. Cameco had a net margin of 14.97% and a return on equity of 8.21%. The firm had revenue of $467.72 million for the quarter, compared to analyst estimates of $819.79 million. During the same period last year, the firm posted $0.14 EPS. Cameco’s quarterly revenue was up 46.7% on a year-over-year basis. Cameco has set its FY 2025 guidance at EPS. On average, sell-side analysts expect that Cameco Corporation will post 1.27 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on CCJ. UBS Group set a $102.00 price objective on shares of Cameco in a report on Tuesday, September 9th. CLSA began coverage on shares of Cameco in a report on Tuesday, September 9th. They set an “outperform” rating and a $102.00 price objective on the stock. Wall Street Zen cut shares of Cameco from a “buy” rating to a “hold” rating in a report on Saturday. TD Securities reissued a “buy” rating on shares of Cameco in a report on Tuesday, August 5th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Cameco in a report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, Cameco presently has a consensus rating of “Buy” and a consensus price target of $89.55.

Cameco Profile

Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.